viimane versioon :
19/11/2024
Tsütoprotektiivne  ravim   Levofolinate calcium  
Süsteravim
Stabiilsus lahustes Stabiilsust mõjutavad tegurid stabiilsust mõjutavad faktorid Sobimatus Manustamis viis Viited pdf
   keemiline struktuur  

Kaubanduslikud nimed erinevates maades   Kaubanduslikud nimed erinevates maades     

Preparaatide nimed on näitlikud ja abianete sisaldus võib erineda sõltuvalt riigist ja laborist

Calc Levof Itaalia
Calcium levofolinat Austria
Elvorine Belgia, Luksemburg, Maroko, Prantsusmaa
Folaxin Hispaania
Folinate EG Belgia
Isovorin Austria, Hispaania, Island, Kreeka, Rootsi, Soome, Suurbritannia, Taani
Levofolatino de calcio Portugal
Levofolene Itaalia
Viited   Süsteravim   Viited : Levofolinate calcium  
tüüp avaldamine
3 ajaleht Trissel LA, Martinez JF.
Compatibility of amifostine with selected drugs during simulated Y-site administration.
Am J Health-Syst Pharm 1995 ; 52: 2208-2212.
155 ajaleht Trissel LA, Martinez JF, Xu QA.
Incompatibility of fluorouracil with leucovorin calcium or levoleucovorin calcium.
Am J Health-Syst Pharm 1995 ; 52: 710-715.
1520 Labor Etude de stabilité des médicaments en Ecoflac®
B Braun 2001
1914 Labor Pemetrexed (Alimta®) - Summary of Product Characteristics
Eli Lilly 2016
2130 ajaleht Lokiec F, Amirault P, Bonnans H, Gauzan MF, Sauvage N, Santoni J.
Stabilité du mélange 5-fluoro-uracil-acide fonique : influence des concentrations, du contenant et de la forme de l’acide folinique.
Bull Cancer 1999 ; 86, 11: 946-954.
2181 ajaleht Milano G, Renée N.
Etude de compatibilité physicochimique 5- fluoro-uracile (nouvelle préparation française) - acide folinique.
Bull Cancer 1995 ; 82: 189-195.
2295 Labor Fosaprepitant (Emend®) - Summary of Product Characteristics
Merck Sharp Dohme 2013
2361 ajaleht Lebitasy M, Hecq J.D, Athanassopoulos A, Vanbeckbergen D, Jamart J, Galanti L.
Effect of freeze-thawing on the long-term stability of calcium levofolinate in 5% dextrose stored on polyolefin infusion bags.
J Clin Pharm Ther 2009 ; 34, 4 : 423-428.
2531 ajaleht Sanogo S, Silimbani P, Gaggeri R, Masini C.
Stability of calcium levofolinate reconstituted in syringes and diluted in NaCl 0.9% and glucose 5% polyolefin/ polyamide infusion bags.
J Oncol Pharm Practice 2021 ; 27, 2: 288-296.
3369 Labor Levofolinate de sodium Medac - Résumé des caractéristiques du produits
MEDAC France 2011
3523 Labor Ceftriaxone (Rocephin®) - Summary of Product Characteristics.
Roche 2018
3546 Labor Cefamandole Flavelab - Résumé des caractéristiques du produit
Panpharma SA 2007
3619 Labor Pamidronate (Pamidronate Actavis®) - Summary of Product Characteristics
Wockhardt 2016
3621 Labor Phosphate dipotassique - Résumé des caractéristiques du produit
Renaudin 2008
3662 Labor Foscavir (Foscarnet®) - Summary of Product Characteristics
Clinigen 2014
3753 Labor Tedizolid phosphate (Sivextro®) - Summary of Product Characteristics
Cubist Pharmaceuticals 2014
3838 Labor Magnesium Sulphate - Summary of Product Characteristics
Martindale Pharmaceuticals Ltd 2007
3933 Labor Acide zolédronique - (Acide zoledronique Teva Pharma) - Résumé des caractéristiques du produit
Teva Laboratoire 2015
4154 Labor Bleomycin sulfate- Summary of Product Characteristics
Accord Health Care 2018
4720 Labor Nuzyra (amadacycline - Full prescribing infomation. Paratek Pharmaceuticals updated May 2021.
Paratek Pharmaceuticals 2021

  Mentions Légales